載入...
Madurella mycetomatis, the main causative agent of eumycetoma, is highly susceptible to olorofim
OBJECTIVES: Eumycetoma is currently treated with a combination of itraconazole therapy and surgery, with limited success. Recently, olorofim, the lead candidate of the orotomides, a novel class of antifungal agents, entered a Phase II trial for the treatment of invasive fungal infections. Here we de...
Na minha lista:
| 發表在: | J Antimicrob Chemother |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7069493/ https://ncbi.nlm.nih.gov/pubmed/31904836 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkz529 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|